272 filings
Page 4 of 14
4
yjy4 imicgy
16 May 19
Aerpio Pharmaceuticals / KEVIN G. PETERS ownership change
5:12pm
8-K
ib0w03
16 May 19
Departure of Directors or Certain Officers
4:49pm
8-K
836peh7fzlnr
9 May 19
Aerpio Reports First Quarter 2019 Financial Results and Provides Business Update
7:13am
DEFA14A
z1yag
30 Apr 19
Additional proxy soliciting materials
4:31pm
4
nyyfcxylk6rf
29 Apr 19
Aerpio Pharmaceuticals / AG NOVARTIS ownership change
5:23pm
SC 13D/A
6hp791
29 Apr 19
Aerpio Pharmaceuticals, Inc.
8:31am
4
ym5v7k ut10kyv
24 Apr 19
Aerpio Pharmaceuticals / AG NOVARTIS ownership change
7:03pm
4
45u 9dessomxin8
15 Apr 19
Aerpio Pharmaceuticals / AG NOVARTIS ownership change
9:26pm
SC 13D/A
8ioxx ael
11 Apr 19
Aerpio Pharmaceuticals, Inc.
8:30am
4
m63n rqsy
10 Apr 19
Aerpio Pharmaceuticals / AG NOVARTIS ownership change
6:26pm
8-K
yk6hqp1j29ga 3f2s
10 Apr 19
Regulation FD Disclosure
7:36am
4
inopdm0p8tkk7ise
5 Apr 19
Aerpio Pharmaceuticals / AG NOVARTIS ownership change
5:14pm
8-K
o1ng1
4 Apr 19
Cost Associated with Exit or Disposal Activities
4:04pm
4
colnf44nhqejexevov7
2 Apr 19
Aerpio Pharmaceuticals / AG NOVARTIS ownership change
8:09pm
SC 13D/A
qmq9zcxklxhf w8peip3
28 Mar 19
Aerpio Pharmaceuticals, Inc.
5:27pm
4
75h51p m51b
28 Mar 19
Aerpio Pharmaceuticals / AG NOVARTIS ownership change
5:16pm
8-K
8wzek
28 Mar 19
Departure of Directors or Certain Officers
4:19pm
8-K
sfzyq3arnxl q77pb
18 Mar 19
Aerpio Pharmaceuticals Announces Results FromTIME-2b Study ofAKB-9778 in Diabetic Retinopathy
7:58am